Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

CardioFocus Inc.

May 2012
CardioFocus Inc. of Marlborough, Mass., developer of the HeartLight endoscopic ablation system for treatment of atrial defibrillation, has announced that a patient was treated with the visually guided device in a US clinical trial. The system incorporates an endoscope for direct visualization of a beating heart, in real time and without radiation. It uses laser energy for efficient and precise ablation. The trial will randomize HeartLight against the NaviStar Thermocool catheter. Only a single ablation procedure with HeartLight will be permitted, while repeat ablation may be performed with Thermocool. The trial will randomize about 350 patients at up to 25 US centers.

laser ablation
The removal of material from a surface by high intensity pulsed or CW laser radiation emission.
Americasatrial defibrillation treatmentBiophotonicsBusinessCardioFocusendoscopic ablation systemheart disease and biophotonicsheart disease and laser ablationHeartlightHeartlight clinical trialsHeartlight EASHeartlight endoscopic ablation systemHeartlight US clinical trialsimaginglaser ablationMassachusettsNaviStar ThermocoolerRapidScanvisualization heartlasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.